Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 1
1993 1
1994 1
1998 1
2001 2
2005 1
2007 1
2008 2
2009 3
2010 3
2011 4
2012 3
2013 1
2014 2
2015 2
2016 3
2017 3
2018 7
2019 1
2020 4
2021 5
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, Capitant C, Rojas-Castro D, Fonsart J, Bercot B, Bébéar C, Cotte L, Robineau O, Raffi F, Charbonneau P, Aslan A, Chas J, Niedbalski L, Spire B, Sagaon-Teyssier L, Carette D, Mestre SL, Doré V, Meyer L; ANRS IPERGAY Study Group. Molina JM, et al. Among authors: charreau i. Lancet Infect Dis. 2018 Mar;18(3):308-317. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8. Lancet Infect Dis. 2018. PMID: 29229440 Clinical Trial.
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Préau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Doré V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF; ANRS IPERGAY Study Group. Molina JM, et al. Among authors: charreau i. N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1. N Engl J Med. 2015. PMID: 26624850 Free article. Clinical Trial.
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Gaborit B, Vanhove B, Lacombe K, Guimard T, Hocqueloux L, Perrier L, Dubee V, Ferre V, Bressollette C, Josien R, Thuaut AL, Vibet MA, Jobert A, Dailly E, Ader F, Brouard S, Duvaux O, Raffi F; POLYCOR study group. Gaborit B, et al. Open Forum Infect Dis. 2023 Oct 20;10(11):ofad525. doi: 10.1093/ofid/ofad525. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 37942459 Free PMC article.
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis.
Zeggagh J, Bauer R, Delaugerre C, Carette D, Fressard L, Charreau I, Chidiac C, Pialoux G, Tremblay C, Cua E, Robineau O, Raffi F, Capitant C, Spire B, Meyer L, Molina JM; Ipergay Study Group. Zeggagh J, et al. Among authors: charreau i. AIDS. 2022 Jul 1;36(8):1129-1134. doi: 10.1097/QAD.0000000000003187. Epub 2022 Feb 9. AIDS. 2022. PMID: 35142708
Prevalence and incidence of HEV among men using HIV pre-exposure prophylaxis: A sub-study of the ANRS IPERGAY trial.
Chaix ML, Leturque N, Gabassi A, Charreau I, Minier M, Pialoux G, Cua É, Chidiac C, Raffi F, Tremblay C, Meyer L, Molina JM, Delaugerre C; ANRS IPERGAY study group. Chaix ML, et al. Among authors: charreau i. J Clin Virol. 2023 Mar;160:105380. doi: 10.1016/j.jcv.2023.105380. Epub 2023 Jan 9. J Clin Virol. 2023. PMID: 36638749 Clinical Trial.
Costs and benefits of on-demand HIV preexposure prophylaxis in MSM.
Durand-Zaleski I, Mutuon P, Charreau I, Tremblay C, Rojas D, Pialoux G, Chidiac C, Capitant C, Spire B, Cotte L, Chas J, Meyer L, Molina JM; ANRS IPERGAY Study Group. Durand-Zaleski I, et al. Among authors: charreau i. AIDS. 2018 Jan 2;32(1):95-102. doi: 10.1097/QAD.0000000000001658. AIDS. 2018. PMID: 29210777
Risk factors for HIV infection among men who have sex with men in the ANRS IPERGAY PrEP trial.
Gras J, Pillet M, Antoni G, Cua E, Charreau I, Raffi F, Chidiac C, Chas J, Tremblay C, Spire B, Delaugerre C, Meyer L, Molina JM; IPERGAY Study group. Gras J, et al. Among authors: charreau i. Sex Transm Infect. 2022 Aug;98(5):383-386. doi: 10.1136/sextrans-2021-055199. Epub 2021 Oct 18. Sex Transm Infect. 2022. PMID: 34663696 Clinical Trial.
Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trial.
Goldwirt L, Bauer R, Liegeon G, Charreau I, Delaugerre C, Cotte L, Pialou G, Cua E, Laghzal A, Buschman L, Anderson PL, Mourah S, Meyer L, Molina JM; ANRS IPERGAY Study Group. Goldwirt L, et al. Among authors: charreau i. J Antimicrob Chemother. 2021 Sep 15;76(10):2675-2680. doi: 10.1093/jac/dkab253. J Antimicrob Chemother. 2021. PMID: 34278433 Clinical Trial.
52 results